Clinical Trials Browser

Phase 2 × Dyspareunia × Clear all

NCT03666819 2023-01-06

Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy

Phase 2 Withdrawn

Breast Carcinoma In Situ, Dyspareunia

NCT02150525 2018-08-09

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Phase 2 Completed

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Dyspareunia